<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CCDC88A</id>
	<title>CCDC88A - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CCDC88A"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CCDC88A&amp;action=history"/>
	<updated>2026-05-15T09:19:34Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=CCDC88A&amp;diff=6070&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin f...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CCDC88A&amp;diff=6070&amp;oldid=prev"/>
		<updated>2021-05-12T15:09:45Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin f...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) [APE] [GRDN] [KIAA1212]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29196338&lt;br /&gt;
|abstract=B cell chronic lymphocytic leukemia (B-CLL), the most common type of leukemia in adults, is still essentially incurable despite the development of novel therapeutic strategies. This reflects the incomplete understanding of the pathophysiology of this disease. A comprehensive proteome analysis of primary human B-CLL cells and B cells from younger as well as elderly healthy donors was performed. For comparison, the chronic B cell leukemia cell line JVM-13 was also included. A principal component analysis comprising 6,945 proteins separated these four groups, placing B cells of aged-matched controls between those of young donors and B-CLL patients, while identifying JVM-13 as poorly related cells. Mass spectrometric proteomics data have been made fully accessible via ProteomeXchange with identifier PXD006570-PXD006572, PXD006576, PXD006578, and PXD006589-PXD006591. Remarkably, B cells from aged controls displayed significant regulation of proteins related to stress management in mitochondria and ROS stress such as [[DLAT]], [[FIS1]], and [[NDUFAB1]], and DNA repair, including [[RAD9A]], [[MGMT]], and [[XPA]]. ROS levels were indeed found significantly increased in B cells but not in T cells or monocytes from aged individuals. These alterations may be relevant for tumorigenesis and were observed similarly in B-CLL cells. In B-CLL cells, some remarkable unique features like the loss of tumor suppressor molecules [[PNN]] and [[JARID2]], the stress-related serotonin transporter [[SLC6A4]], and high expression of [[ZNF207]], [[CCDC88A]], [[PIGR]] and [[ID3]], otherwise associated with stem cell phenotype, were determined. Alterations of metabolic enzymes were another outstanding feature in comparison to normal B cells, indicating increased beta-oxidation of fatty acids and increased consumption of glutamine. Targeted metabolomics assays corroborated these results. The present findings identify a potential proteome signature for immune senescence in addition to previously unrecognized features of B-CLL cells and suggest that aging may be accompanied by cellular reprogramming functionally relevant for predisposing B cells to transform to B-CLL cells.&lt;br /&gt;
|mesh-terms=* Adult&lt;br /&gt;
* Aged&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* B-Lymphocytes&lt;br /&gt;
* Cell Line, Tumor&lt;br /&gt;
* Female&lt;br /&gt;
* Humans&lt;br /&gt;
* Leukemia, Lymphocytic, Chronic, B-Cell&lt;br /&gt;
* Male&lt;br /&gt;
* Metabolomics&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Neoplasm Proteins&lt;br /&gt;
* Proteomics&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795392&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>